Recall two batches of Trepadio 50 mg and 100 mg FCT
2025-02-25
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Trepadio 50 mg FCT LACOSAMIDE 2103221859 6480 Jazeera Pharmaceutical Industries (JPI) Trepadio 100 mg FCT 2102221756 6477
التصنيف
ملف
التاريخ
2025-01-05
اسم المستحضر
Trepadio 50 mg FCT / Trepadio 100 mg FCT
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
Saudi FDA issued Recall two batches of Trepadio 50 mg and 100 mg FCT due to not comply with the approved specifications. Jazeera Pharmaceutical Industries (JPI) is voluntarily recalling batches.
التوصيات
For healthcare professionals, Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
for patients
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or Saudi FDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.